Search:   [Advanced]

Search Results

Search for "Amprenavir" returned 47 results

previous123next

Showing 1-20 out of 47

DrugBank ID	Name	Formula	Weight
DB00701	Amprenavir	C25H35N3O6S	505.6270
	Amprenavir Amprenavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an ...
DB01319	Fosamprenavir	C25H36N3O9PS	585.6070
	... The antiacid decreases the absorption of amprenavir Cisapride Amprenavir increases the effect and toxicity of cisapride Clorazepate Amprenavir increases the effect and toxicity of ...
DB01244	Bepridil	C24H34N2O	366.5396
	Amprenavir Amprenavir increases the effect and toxicity of bepridil Astemizole Increased risk of cardiotoxicity and arrhythmias Atazanavir Atazanavir increases the effect and toxicity of bepridil ...
DB00690	Flurazepam	C21H23ClFN3O	387.8780
	... increases the effect of the benzodiazepine Fosamprenavir Amprenavir increases the effect and toxicity of benzodiazepine Fosphenytoin Possible increased levels of the hydantoin, decrease of ...
DB00628	Clorazepate	C16H11ClN2O3	314.7230
	... increases the effect of the benzodiazepine Fosamprenavir Amprenavir increases the effect and toxicity of benzodiazepine Fosphenytoin Possible increased levels of the hydantoin, decrease of ...
DB01378	Magnesium	Mg	24.3050
	... UHFFFAOYAC Alendronate Formation of non-absorbable complexes Amprenavir The antiacid decreases the absorption of amprenavir Atazanavir This gastric pH modifier decreases the levels/effects of ...
DB01100	Pimozide	C28H29F2N3O	461.5462
	Amprenavir Amprenavir increases the effect and toxicity of pimozide Aprepitant Increased risk of cardiotoxicity and arrhythmias Atazanavir The protease inhibitor increases the effect and toxicity ...
DB00705	Delavirdine	C22H28N6O3S	456.5610
	... Aluminium The antiacid decreases the effect of delavirdine Amprenavir Decreased levels of delavirdine with increased levels of amprenavir Astemizole Increased risk of cardiotoxicity and ...
DB00829	Diazepam	C16H13ClN2O	284.7400
	Amprenavir Amprenavir increases the effect and toxicity of benzodiazepine Cimetidine Cimetidine increases the effect of the benzodiazepine Clarithromycin The macrolide increases the effect of the ...
DB00897	Triazolam	C17H12Cl2N4	343.2100
	... increases the effect of the benzodiazepine Fosamprenavir Amprenavir increases the effect and toxicity of benzodiazepine Fosphenytoin Possible increased levels of the hydantoin, decrease of ...
DB01373	Calcium	Ca	40.0780
	... Fosamprenavir The antiacid decreases the absorption of amprenavir Grepafloxacin Formation of non-absorbable complexes Ibandronate Formation of non-absorbable complexes Indinavir The antiacid ...
DB00227	Lovastatin	C24H36O5	404.5396
	... Increased risk of myopathy/rhabdomyolysis Fosamprenavir Amprenavir can possibly increase the statin toxicity Gemfibrozil Increased risk of myopathy/rhabdomyolysis Imatinib Imatinib increases ...
DB00683	Midazolam	C18H13ClFN3	325.7670
	... increases the effect of benzodiazepine Fosamprenavir Amprenavir increases the effect and toxicity of benzodiazepine Fosphenytoin Possible increased levels of the hydantoin, decrease of ...
DB01076	Atorvastatin	C33H35FN2O5	558.6398
	Amprenavir Amprenavir can possibly increase the statin Atazanavir Atazanavir increases the effect and toxicity of the statin Bezafibrate Increased risk of myopathy/rhabdomyolysis Bosentan Bosentan ...
DB00404	Alprazolam	C17H13ClN4	308.7650
	Amprenavir Increases the effect and toxicity of benzodiazepine Aprepitant Increases the effect and toxicity of benzodiazepine Carbamazepine Reduces the effect of the benzodiazepine Cimetidine ...
DB02703	Fusidic Acid	C31H48O6	516.7092
	Amprenavir The protease inhibitor increases the effect and toxicity of fusidic acid Atorvastatin Increased risk of myopathy/rhabdomyolysis Fosamprenavir The protease inhibitor increases the effect ...
DB00320	Dihydroergotamine	C33H37N5O5	583.6774
	... and severe ischemia with this combination Fosamprenavir Amprenavir increases the effect and toxicity of ergot derivative Frovatriptan Possible severe and prolonged vasoconstriction Indinavir ...
DB00615	Rifabutin	C46H62N4O11	847.0047
	... The rifamycin decreases the effect of tricyclics Amprenavir Amprenavir increases the effect and toxicity of rifabutin Anisindione The rifamycin decreases the anticoagulant effect Atazanavir ...
DB00696	Ergotamine	C33H35N5O5	581.6615
	... and severe ischemia with this combination Fosamprenavir Amprenavir increases the effect and toxicity of ergot derivative Frovatriptan Possible severe and prolonged vasoconstriction Indinavir ...
DB00822	Disulfiram	C10H20N2S4	296.5390
	... Aminophylline Increases the effect and toxicity of theophylline Amprenavir Increased risk of side effects (oral solution) Anisindione Increases the anticoagulant effect Chlorzoxazone Increases ...

Showing 1-20 out of 47

previous123next

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.